You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Caring for Patients in Various Stages of Type 1 Diabetes

  • Authors: Jay S. Skyler, MD, MACP, FRCP; Kimber Simmons, MD, MS; William H. Polonsky, PhD, CDCES
  • CME / ABIM MOC / CE Released: 9/22/2022
  • Valid for credit through: 9/22/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for diabetologists, endocrinologists, pediatricians, nurses, nurse practitioners, and other clinicians who care for patients with or at risk for T1D.

The goal of this activity is that members of the diabetes healthcare team will be better able to screen, stage, manage, and monitor patients at various stages of T1D.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Strategies for effective monitoring and follow-up in patients with various stages of T1D
  • Have greater competence related to
    • Team-based screening and staging of patients at high risk of T1D
    • Team-based care of patients with T1D after screening and staging has been completed


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Jay S. Skyler, MD, MACP, FRCP

    Professor of Medicine, Pediatrics, & Psychology
    Division of Endocrinology, Diabetes, & Metabolism
    Deputy Director for Clinical Research & Academic Programs
    Diabetes Research Institute
    University of Miami Miller School of Medicine
    Miami, Florida

    Disclosures

    Jay S. Skyler, MD, MACP, FRCP, has the following relevant financial relationships:
    Consultant or advisor for: Abvance; Adocia; Altheia; Arecor; AstraZeneca; Avotres; Bayer; COUR; Dance Biopharm/Aerami; Diasome; Enthera; Imcyse; Immunomolecular Therapeutics; Kriya; Novo Nordisk; Oramed; Orgenesis; Precigen ActoBiotics; Provention Bio; Sanofi; Signos; Vertex; Viacyte
    Stock options from: Abvance; Applied Therapeutics; Avotres; Dance Biopharm/Aerami; Dexcom; Immnomolecular Therapeutics; Oramed; Orgenesis; Signos
    Owns stock (publicly traded) in: Applied Therapeutics; Dexcom; Oramed; Orgenesis
    Other: Board of Directors: Applied Therapeutics; Dexcom

Faculty

  • Kimber Simmons, MD, MS

    Assistant Professor of Pediatrics
    Barbara Davis Center for Diabetes
    University of Colorado School of Medicine
    Aurora, Colorado

    Disclosures

    Kimber Simmons, MD, MS, has the following relevant financial relationships:
    Consultant or advisor for: Provention Bio; Dexcom
    Speaker or member of speakers bureau for: Dexcom
    Research funding from: Novartis; Provention Bio

  • William H. Polonsky, PhD, CDCES

    Associate Clinical Professor
    University of California, San Diego
    President
    Behavioral Diabetes Institute
    San Diego, California

    Disclosures

    William H. Polonsky, PhD, CDCES, has the following relevant financial relationships:
    Consultant or advisor for: Abbott Diabetes Care; Boehringer Ingelheim; Dexcom; Eli Lilly; Insulet; Intuity; Mannkind; Novo Nordisk; Sanofi; Vertex
    Research funding from: Abbott Diabetes Care; Dexcom
    Owns stock (publicly traded) in: Provention Bio

Editors

  • Anne G. Le, PharmD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Anne G. Le, PharmD, has no relevant financial relationships.

  • Frederick Stange, DO

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50. MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Caring for Patients in Various Stages of Type 1 Diabetes

Authors: Jay S. Skyler, MD, MACP, FRCP; Kimber Simmons, MD, MS; William H. Polonsky, PhD, CDCESFaculty and Disclosures

CME / ABIM MOC / CE Released: 9/22/2022

Valid for credit through: 9/22/2023

processing....

Educational Impact Challenge

The goal of this activity is that members of the diabetes healthcare team will be better able to screen, stage, manage, and monitor patients at various stages of T1D.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print